Loading insider details...
Beta
Latest Form 4 (Oct 2, 2026): Exercise/Conversion of 3,500 ORIC shares, $5.6K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Oct 2, 2026 | Oric Pharmaceuticals, Inc. (ORIC) | Exercise/Conversion | 3,500 | $5.6K |
| Jul 28, 2026 | Oric Pharmaceuticals, Inc. (ORIC) | Exercise/Conversion | 3,500 | $5.6K |
| Jul 8, 2026 | Oric Pharmaceuticals, Inc. (ORIC) | Sale | 300 | $3.6K |
| Feb 19, 2026 | Enliven Therapeutics, Inc. (ELVN) | Sale | 1,230 | $32.2K |
| Feb 18, 2026 | Enliven Therapeutics, Inc. (ELVN) | Grant/Award | 19,234 | n/a |
| Jan 22, 2026 | Enliven Therapeutics, Inc. (ELVN) | Sale | 512 | $13.5K |
| Jan 21, 2026 | Oric Pharmaceuticals, Inc. (ORIC) | Sale | 3,500 | $42.0K |
| Jan 12, 2026 | Enliven Therapeutics, Inc. (ELVN) | Sale | 1,620 | $40.5K |
| Jan 6, 2026 | Oric Pharmaceuticals, Inc. (ORIC) | Grant/Award | 40,000 | n/a |
| Oct 3, 2025 | Oric Pharmaceuticals, Inc. (ORIC) | Exercise/Conversion | 31,353 | $50.2K |